Prescribing pattern of antipsychotic drugs in the Italian general population 2000–2005: a focus on elderly with dementia
Authors:
- Gianluca TrifiròGTGianluca Trifirò
- Giovanna SiniGSGiovanna Sini
- Miriam C.J.M. SturkenboomMSMiriam C.J.M. Sturkenboom
- Nicola VanacoreNVNicola Vanacore
- Giampiero MazzagliaGMGiampiero Mazzaglia
- Achille P. CaputiACAchille P. Caputi
- Claudio CricelliCCClaudio Cricelli
- Ovidio BrignoliOBOvidio Brignoli
- Eugenio AgugliaEugenio Aguglia
- Giovanni BiggioGBGiovanni Biggio
- Fabio SamaniFSFabio Samani
- 1 January 2010
- journal article
- Published by Wolters Kluwer Health in International Clinical Psychopharmacology
- Vol. 25 (1) , 22-28
Abstract
The objective of this study was to evaluate the antipsychotic drug prescribing pattern in the Italian general population, elderly, and especially elderly with dementia, in relation to the safety warnings issued by international regulatory agencies about the risk of cerebrovascular adverse events and mortality in 2004 and 2005. A cohort study was conducted using the electronic medical records of the Italian general practice database ‘Health Search/Thales’. On the basis of prescription data, 1-year and monthly prevalence estimates were calculated for atypical and typical antipsychotic use in general population, elderly, and elderly demented outpatients. One-year prevalence of individual medication use in elderly demented patients was calculated as well. The prevalence of use of atypical agents in demented patients progressively increased from 2000 [0.2 (0.05–0.7) per 10 000] until the beginning of 2004 [9.7 (8.1–11.6) per 10 000], after which a slight decrease started, whereas the prevalence of use of typical antipsychotics decreased from 2001 [15.7 (13.5–18.2) per 10 000] until 2004 [10.7 (9.0–12.7) per 10 000], then slightly increased in December 2005 [12.1 (10.4–14.2) per 10 000]. Monthly trends in general population and elderly were quite similar and differed significantly from the trend in elderly with dementia: stable use of atypicals from 2002 to 2005 and strong reduction of typicals from 2001 to the end of 2004. The recent safety warnings led to an increasing trend in the use of typical agents and decreasing trend in the use of atypical agents in elderly demented outpatients in Italy. Similar trends were not observed in general population and elderly as a whole.Keywords
This publication has 19 references indexed in Scilit:
- The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trialThe Lancet Neurology, 2009
- Is new drug prescribing in primary care specialist induced?BMC Health Services Research, 2009
- Influence of the FDA Talk Paper upon the use of atypical antipsychotics for psychotic symptoms in older patients with dementia in JapanPsychogeriatrics, 2006
- Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population‐based observational studyBritish Journal of Clinical Pharmacology, 2003
- Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription databaseInternational Clinical Psychopharmacology, 2003
- Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners in Diabetic PatientsDiabetes Care, 2003
- Secondary Prevention of Stroke in ItalyStroke, 2003
- Variations in prescribing atypical antipsychotic drugs in primary care: cross‐sectional studyPharmacoepidemiology and Drug Safety, 2002
- Prescription of Antipsychotic Drugs by Office-Based Physicians in the United States, 1989-1997Psychiatric Services, 2002
- Clinical information for research; the use of general practice databasesJournal of Public Health, 1999